Amgen spends $10 billion to buy back 52.1 million shares

You are here: Home > Central Coast Health Watch > Current Article

Amgen spends $10 billion to buy back 52.1 million shares

By Staff Report / Tuesday, March 6th, 2018 / Comments Off on Amgen spends $10 billion to buy back 52.1 million shares

Amgen completed a $10 billion share buyback on March 5, rounding up around 52.1 million shares of its common stock for $192 apiece. The shares bought in the offer represent about 7.2 percent of total outstanding shares, the company said in a March 6 press release. The Thousand Oaks-based biotech giant announced its intent to…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.